Key Market Indicators
Sales of Slovak antihypertensive medicines are set to reach $27 million by 2026, according to a new report. The report, which was released on Monday, estimated the market size was $25 million in 2021. This represents an annual growth rate of 1.7%. However, since 2001, demand in Slovakia has decreased by 0.5% year-on-year. In 2021, Slovakia was ranked 13th in the global market, with South Korea overtaking with $24.64 million. Italy, Spain, and Australia ranked second, third, and fourth respectively.
